• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Molecular Instruments® Introduces the HCR™ HiFi Encoder: Game-Changing Multiplex Immunofluorescence

By: Molecular Instruments via Business Wire
September 11, 2025 at 15:45 PM EDT

Molecular Instruments® (MI), founded by the inventor of the HCR™ technology, today announces the upcoming release of the HCR™ HiFi Encoder, a breakthrough advance in multiplex immunofluorescence (IF) that enables users to robustly encode best-in-class quantitative signal amplification to their favorite primary antibodies. The HCR™ HiFi Encoder represents a game-changer across the multi-decade IF landscape because multiplex experiments can now be performed without relying on predetermined panels of primary antibodies and without use of secondary antibodies. Instead, the HCR™ HiFi Encoder offers the flexibility to simultaneously employ multiple user-provided primaries from the same host species/isotype (e.g., mouse IgG1 or rabbit IgG), thus eliminating the traditional multiplexing tradeoffs that have constrained previous IF technologies.

HCR™ HiFi Encoder. Your Trusted Antibodies. Robust Amplification Encoding.

With the HCR™ HiFi Encoder, researchers can robustly encode the primary antibodies they already use and trust to perform amplified multiplex, quantitative, high-resolution HCR™ Gold IF.

Key Features

  • Robust encoding — Encode your favorite primaries without affecting target-binding affinity.
  • Same-species multiplexing — Perform multiplex IF using multiple primary antibodies from the same host species and isotype with no cross-reactivity.
  • Best-in-class amplification — Use 1-step quantitative HCR™ Gold signal amplification for protein imaging, leveraging the dynamic nanotechnology that has redefined the state-of-the-art for RNA imaging; small amplification components penetrate the sample without interaction, then execute triggered growth of bright amplification polymers at the site of targets, achieving exceptional signal-to-background ratios and unprecedented sample penetration (e.g., 1 cm).
  • Unified protein and RNA imaging — Combine HCR™ Gold IF with HCR™ Gold RNA-FISH (fluorescence in situ hybridization), performing 1-step quantitative HCR™ Gold signal amplification for 10 protein and RNA targets simultaneously.

“Seasoned IF practitioners are all too aware that existing IF products face an unfortunate tradeoff – either limiting flexibility through imposition of predetermined panels for technologies that are not robust when applied to user’s primaries of choice, or else limiting multiplexing through use of secondary antibodies that prohibit use of same-species/isotype primaries,” said Dr. Aneesh Acharya, Chief Commercial Officer at Molecular Instruments. “The HCR™ HiFi Encoder escapes this tradeoff by giving researchers the flexibility to robustly and routinely encode best-in-class signal amplification to their trusted primary antibodies. We are excited for the HCR™ HiFi Encoder and HCR™ Gold IF to unleash the creativity of researchers that have long been impeded by the historical constraints of IF technologies.”

“In 2018, HCR™ RNA-FISH leveraged dynamic nanotechnology to overcome multi-decade bioimaging challenges and redefine the state-of-the-art for RNA imaging,” said Dr. Harry Choi, Co-founder & CEO of Molecular Instruments. “In 2025, with the upcoming launch of the HCR™ HiFi Encoder for HCR™ Gold IF, we are leveraging our many years of RNA learnings to overcome multi-decade IF challenges and correspondingly redefine the state-of-the-art for protein imaging. This is an important milestone for Molecular Instruments and the community of researchers our products support as we expand our breakthrough HCR™ imaging platform to encompass both the RNA and protein imaging spaces.”

Pre-Orders

Customers can pre-order Launch Edition bundles of the HCR™ HiFi Encoder. Initial availability of Launch Edition bundles is limited; pre-orders will be filled in the order placed starting in late September 2025.

About Molecular Instruments

Molecular Instruments® (www.molecularinstruments.com) develops and synthesizes molecular kits powered by the breakthrough HCR™ imaging platform for applications in academic research, drug development, synthetic biology, and clinical pathology and diagnostics.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250908322176/en/

"We are excited for the HCR™ HiFi Encoder and HCR™ Gold IF to unleash the creativity of researchers that have long been impeded by the historical constraints of IF technologies."

Contacts

Media Contact:

Joyce Yoo

Associate Director of Marketing

joyce@molecularinstruments.com

More News

View More
News headline image
Wendy’s Is Down Sharply—Is the Dividend a Bargain or Value Trap? ↗
March 01, 2026
Via MarketBeat
Tickers WEN
News headline image
3 Unique ETFs Launched in 2026 to Vary Your Investment Strategy ↗
March 01, 2026
Via MarketBeat
Topics ETFs
News headline image
Home Depot & Lowe’s: Buying the Earnings Dip ↗
March 01, 2026
Via MarketBeat
Tickers HD LOW
News headline image
AT&T's Earnings Glow-Up Can't Hide These Red Flags ↗
February 28, 2026
Via MarketBeat
Tickers LUMN T
News headline image
Risk-Off: Global Trade Uncertainty Is Shaking Crypto, But Not These 2 Stocks ↗
February 28, 2026
Via MarketBeat
Tickers COIN MARA

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.00
+2.08 (1.00%)
AAPL  264.18
-8.77 (-3.21%)
AMD  200.21
-3.47 (-1.70%)
BAC  49.83
-2.47 (-4.72%)
GOOG  311.43
+4.28 (1.39%)
META  648.18
-8.83 (-1.34%)
MSFT  392.74
-8.98 (-2.24%)
NVDA  177.19
-7.70 (-4.16%)
ORCL  145.40
-4.91 (-3.27%)
TSLA  402.51
-6.07 (-1.49%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap